Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy. [electronic resource]
Producer: 20020422Description: 591-7 p. digitalISSN:- 1077-4114
- Adolescent
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Asparaginase -- administration & dosage
- Bone Marrow -- pathology
- Bone Marrow Transplantation
- Burkitt Lymphoma -- drug therapy
- Child
- Child, Preschool
- Combined Modality Therapy
- Daunorubicin -- administration & dosage
- Disease-Free Survival
- Female
- Gene Rearrangement, B-Lymphocyte, Heavy Chain
- Genes, Immunoglobulin
- Humans
- Immunoglobulin Heavy Chains -- genetics
- Infant
- Leukemia-Lymphoma, Adult T-Cell -- drug therapy
- Life Tables
- Male
- Methotrexate -- administration & dosage
- Neoplasm, Residual
- Polymerase Chain Reaction
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Prednisolone -- administration & dosage
- Recurrence
- Remission Induction
- Retrospective Studies
- Risk
- Survival Analysis
- Survival Rate
- Treatment Outcome
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Comparative Study; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.